$HSTC
HST Global Inc

2020 Q2 Form 10-Q Financial Statement

#000167479620000032 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $43.82K $34.76K
YoY Change 26.06% -13.1%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $43.82K $34.76K
YoY Change 26.07% -13.1%
Operating Profit -$43.82K -$34.76K
YoY Change 26.08% -1.97%
Interest Expense $206.00 -$8.940K
YoY Change -102.3% -10.6%
% of Operating Profit
Other Income/Expense, Net -$206.00 -$8.937K
YoY Change -97.69% 0.0%
Pretax Income -$44.03K -$43.70K
YoY Change 0.75% 9.25%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$44.03K -$43.70K
YoY Change 0.75% 9.25%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$10.36K -$17.69K
COMMON SHARES
Basic Shares Outstanding 4.248M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.470K $0.00
YoY Change
Cash & Equivalents $1.471K $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.470K $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.470K $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $1.470K $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $61.87K $96.73K
YoY Change -36.04% -81.03%
Accrued Expenses $220.00 $193.2K
YoY Change -99.89% -86.3%
Deferred Revenue
YoY Change
Short-Term Debt $21.68K $675.0K
YoY Change -96.79% -50.73%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.76K $964.9K
YoY Change -91.32% -70.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $83.76K $964.9K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $83.76K $964.9K
YoY Change -91.32% -70.58%
SHAREHOLDERS EQUITY
Retained Earnings -$5.445M -$5.881M
YoY Change -7.42% 3.09%
Common Stock $4.248K $51.72K
YoY Change -91.79% 40.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$82.29K -$964.9K
YoY Change
Total Liabilities & Shareholders Equity $1.470K $0.00
YoY Change

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$44.03K -$43.70K
YoY Change 0.75% 9.25%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.630K -$13.10K
YoY Change -64.66% 31.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.110K 13.10K
YoY Change -53.36% 31.0%
NET CHANGE
Cash From Operating Activities -4.630K -13.10K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 6.110K 13.10K
Net Change In Cash 1.480K 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$4.630K -$13.10K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Entity File Number
EntityFileNumber
000-15303
dei Entity Registrant Name
EntityRegistrantName
HST Global, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
73-1215433
dei Entity Address Address Line1
EntityAddressAddressLine1
150 Research Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Hampton
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23666
dei City Area Code
CityAreaCode
757
dei Local Phone Number
LocalPhoneNumber
766-6100
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4247993 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1471 usd
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1955 usd
CY2020Q2 us-gaap Assets Current
AssetsCurrent
1471 usd
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1955 usd
CY2020Q2 us-gaap Assets
Assets
1471 usd
CY2019Q4 us-gaap Assets
Assets
1955 usd
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1865 usd
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3910 usd
CY2020Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
60000 usd
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1475 usd
CY2020Q2 fil Accrued Interest Related Party
AccruedInterestRelatedParty
222 usd
CY2019Q4 fil Accrued Interest Related Party
AccruedInterestRelatedParty
0 usd
CY2020Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
21676 usd
CY2019Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 usd
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
83763 usd
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5385 usd
CY2020Q2 us-gaap Liabilities
Liabilities
83763 usd
CY2019Q4 us-gaap Liabilities
Liabilities
5385 usd
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4247993 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4247993 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4247993 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4247993 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
4248 usd
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
4248 usd
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5358236 usd
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5358236 usd
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5444777 usd
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5365914 usd
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-82293 usd
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-3430 usd
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1471 usd
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1955 usd
CY2020Q2 us-gaap Revenues
Revenues
0 usd
CY2019Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2020Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
30000 usd
CY2019Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
30000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
60000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
60000 usd
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13822 usd
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4758 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18640 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11066 usd
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
43822 usd
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
34758 usd
us-gaap Operating Expenses
OperatingExpenses
78640 usd
us-gaap Operating Expenses
OperatingExpenses
71066 usd
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-43822 usd
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-34758 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-78640 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-71066 usd
CY2020Q2 us-gaap Interest Expense
InterestExpense
206 usd
CY2019Q2 us-gaap Interest Expense
InterestExpense
8937 usd
us-gaap Interest Expense
InterestExpense
222 usd
us-gaap Interest Expense
InterestExpense
17874 usd
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-206 usd
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8937 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-222 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17874 usd
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44028 usd
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43695 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-78862 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-88940 usd
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-44028 usd
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-43695 usd
us-gaap Net Income Loss
NetIncomeLoss
-78862 usd
us-gaap Net Income Loss
NetIncomeLoss
-88940 usd
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4247993 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2464568 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4247993 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2447993 shares
us-gaap Profit Loss
ProfitLoss
-78862 usd
us-gaap Profit Loss
ProfitLoss
-88940 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
0 usd
us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
745 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
12476 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3520 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2779 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
60000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
60000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
222 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
17874 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9684 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13100 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
9200 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
13100 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9200 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13100 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-484 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 usd
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1955 usd
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1471 usd
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
fil Conversionof Accounts Payable
ConversionofAccountsPayable
0 usd
fil Conversionof Accounts Payable
ConversionofAccountsPayable
1509680 usd
fil Conversionof Notes Payable
ConversionofNotesPayable
0 usd
fil Conversionof Notes Payable
ConversionofNotesPayable
985296 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><b>NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES </b></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition has been accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations.  Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The accompanying interim financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnotes necessary for a complete presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. The unaudited quarterly financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K of the Company as of and for the fiscal year ended December 31, 2019. The results of operations for the period ended June 30, 2020, are not necessarily indicative of the results for a full-year period.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">HST Global, Inc. is an integrated Health and Wellness Biotechnology company that intends to developing and/or acquiring a network of Wellness Centers worldwide with the primary focus on homeopathic and alternative treatments of late stage cancer and other life threatening diseases.  In addition, the Company intends to acquire innovative products for the treatment of life threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer and/or life threatening diseases.</p>
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Basis of Presentation</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K and 10-Q.  </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Use of Estimates</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>

Files In Submission

Name View Source Status
0001674796-20-000032-index-headers.html Edgar Link pending
0001674796-20-000032-index.html Edgar Link pending
0001674796-20-000032.txt Edgar Link pending
0001674796-20-000032-xbrl.zip Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hstc-20200630.htm Edgar Link pending
hstc-20200630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
hstc-20200630_lab.xml Edgar Link unprocessable
hstc-20200630_def.xml Edgar Link unprocessable
hstc-20200630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
hstc-20200630_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hstc-20200630_cal.xml Edgar Link unprocessable